Large Decrease Seen in Antidepressant Use During Pregnancy
By Elana Gotkine HealthDay Reporter
MONDAY, Feb. 3, 2025 -- There has been a large decrease in antidepressant use during pregnancy and no corresponding increase in psychotherapy claims, according to a research letter published online Jan. 30 in JAMA Network Open.
Claire Boone, Ph.D., from McGill University in Montreal, and colleagues measured antidepressant medication fills and psychotherapy claims of women and their spouses for two years before and two years after the birth of a child (2009 to 2019). The study included 385,731 women.
The researchers found that 4.3 and 2.2 percent of women filled an antidepressant prescription in the year before pregnancy and during pregnancy, respectively, a reduction of 48.8 percent. No similar change was seen in antidepressant use among 217,877 spouses, indicating that this behavior was not associated with co-occurring changes in the couple's life. During pregnancy, there was a slight decrease in psychotherapy claims related to a trend line. Women's mean medication fills returned to the prepregnancy trend line within one month of giving birth.
"We documented a large decrease in antidepressant use without an accompanying increase in psychotherapy during pregnancy," the authors write. "These findings, coupled with evidence of mental health challenges during and after pregnancy, suggest the need for increased focus on and discussion about mental health treatments by pregnant women and their clinicians."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Combinations of Chronic, Physical Illnesses Up the Risk of Subsequent Depression
WEDNESDAY, May 21, 2025 -- Certain groups of physical multimorbidity may be associated with a higher risk of subsequent depression, according to a study published online May 13...
Calorie Restrictions, Low-Fat Diets May Reduce Depressive Symptoms
MONDAY, May 19, 2025 -- Among adults with elevated cardiometabolic risk, calorie restrictions and low-fat diets may reduce depressive symptoms, according to a review published...
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.